Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Secreted frizzled-related protein 1 (SFRP1) is a secreted glycoprotein and member of the frizzled-related protein family, characterized by a cysteine-rich domain homologous to the Wnt-binding region of Frizzled receptors. SFRP1 functions as a soluble antagonist of canonical Wnt signaling by directly binding Wnt ligands, preventing receptor activation, and reducing β-catenin levels. Regulation by SFRP1 impacts cell growth, differentiation, cell cycle progression, apoptosis, and tissue patterning—especially in cancer, where loss or silencing of SFRP1 leads to unchecked Wnt pathway activation. Additional functions involve retinal cell polarity, angiogenesis, and possible roles in fibrotic disease. SFRP1 is considered a putative therapeutic target, especially in oncology and regenerative medicine.
Antagonism of Wnt ligands via binding and sequestration. Inhibition of β-catenin signaling downstream of Wnt pathway. Modulation of cell cycle (delays G1 phase, inhibits entry into S phase). Inhibition of WNT1/WNT4-mediated TCF-dependent transcription.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Secreted frizzled-related protein 1 (SFRP1).